SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: fred hayes who wrote (23515)1/23/2015 1:38:20 AM
From: The Ox  Read Replies (1) of 23519
 
I think the main reason is the size of the short position.

I just don't understand how it could be this low.


Over 1/3 of the float is being shorted. It will take major news to break the trend, at least that's what I would expect. Until someone makes an offer to buy them or they find a way to present some favorable news, the shorts will likely keep pounding this one, as it's been very good to them thus far. I think this will change at some point this year. Have no idea when or why?

Looks like there's more to their product line than the stock price is suggesting. Also, even though they have all that cash on hand, they also have some debt, so (I believe) cash net the debt is closer to $0.75/share and it may be a little lower than that......

It's usually wise to respect short positions of this size. My concern is that there's something the shorts know about the company that management hasn't discussed but that's FUD and nothing to trade on (to say the least).
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News